NCT05744635View on ClinicalTrials.gov

Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients

RecruitingOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

May 10, 2023

Primary Completion Date

March 1, 2026

Study Completion Date

June 1, 2026

Conditions
Liver Failure
Interventions
DRUG

Tacrolimus

Tacrolimus received as part of routine clinical care

Trial Locations (2)

1000

RECRUITING

University Medical Center Ljubljana, Division of Internal Medicine, Department of Gastroenterology, Ljubljana

1085

RECRUITING

Semmelweis University, Department of Surgery, Transplantation and Gastroenterology, Budapest

All Listed Sponsors
collaborator

Chiesi Slovenija, d.o.o.

INDUSTRY

lead

Chiesi Hungary Ltd.

INDUSTRY